ARROWHEAD PHARMACEUTICALS, INC.
Industry: Life Sciences ・ $ARWR on Nasdaq
Insider Sale
+$1,865,268
-1.52%
Shares
Shares Volume: 57,499 Shares
Average Share Price: $32.44
INSIDER
Anzalone Christopher Richard
Chief Executive Officer (Director)
reported on Feb 2 2024
traded on Jan 31 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 3,715,048 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,654,574.57 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 23 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $636,336.56 |
| COMPANY PREVIOUS TRADES |